Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10, monoclonal antibody

D. Soligo, D. Delia, A. Oriani, G. Cattoretti, A. Orazi, V. Bertolli, N. Quirici, G. Lambertenghi Deliliers

Research output: Contribution to journalArticlepeer-review


Monoclonal antibody QBEND10 is reactive with the CD34 antigen in aldehyde-fixed, decalcified, paraffin-embedded bone marrow biopsies. In normal bone marrow it stained endothelial cells lining arterioles and capillaries, sinusoidal (littoral) cells and 0.89% of all haemopoietic cells. QBEND10+ mononuclear cells were seen as isolated, randomly distributed mononuclear cells in normal and regenerating bone marrows. Conversely, QBEND10+ cells were increased and present in aggregates of three or more cells in 6/8 cases of acute leukemia; in two cases of CD34-negative leukemia and in two patients after complete remission no aggregates were seen. QBEND10 immunohistochemistry may therefore be useful for diagnosis and follow-up of myeloid leukemias. In addition, increased numbers of CD34+ cells arranged in clusters were seen in 4/9 cases of refractory anemia with excess blasts (RAEB), 1 case of chronic myelomonocytic leukemia, 3/3 cases of RAEB in transformation, and in 3/7 cases of chronic myelogenous leukemia: in all these cases, CD34 staining of the bone biopsy may have prognostic value. QBEND10+ endothelial cells were significantly increased in all the pathological conditions examined (1.43% of all nucleated cells versus 0.80% in normal bone marrow; p = 0.0063), but especially in myeloid leukemias and in two fibrotic syndromes examined.

Original languageEnglish
Pages (from-to)1026-1030
Number of pages5
Issue number12
Publication statusPublished - Dec 1991

ASJC Scopus subject areas

  • Cancer Research
  • Hematology


Dive into the research topics of 'Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10, monoclonal antibody'. Together they form a unique fingerprint.

Cite this